Literature DB >> 16931977

Closed-loop control of mean arterial blood pressure during surgery with alfentanil: clinical evaluation of a novel model-based predictive controller.

Martin Luginbühl1, Christian Bieniok, Daniel Leibundgut, Rolf Wymann, Andrea Gentilini, Thomas W Schnider.   

Abstract

BACKGROUND: In contrast to hypnosis, there is no surrogate parameter for analgesia in anesthetized patients. Opioids are titrated to suppress blood pressure response to noxious stimulation. The authors evaluated a novel model predictive controller for closed-loop administration of alfentanil using mean arterial blood pressure and predicted plasma alfentanil concentration (Cp Alf) as input parameters.
METHODS: The authors studied 13 healthy patients scheduled to undergo minor lumbar and cervical spine surgery. After induction with propofol, alfentanil, and mivacurium and tracheal intubation, isoflurane was titrated to maintain the Bispectral Index at 55 (+/- 5), and the alfentanil administration was switched from manual to closed-loop control. The controller adjusted the alfentanil infusion rate to maintain the mean arterial blood pressure near the set-point (70 mmHg) while minimizing the Cp Alf toward the set-point plasma alfentanil concentration (Cp Alfref) (100 ng/ml).
RESULTS: Two patients were excluded because of loss of arterial pressure signal and protocol violation. The alfentanil infusion was closed-loop controlled for a mean (SD) of 98.9 (1.5)% of presurgery time and 95.5 (4.3)% of surgery time. The mean (SD) end-tidal isoflurane concentrations were 0.78 (0.1) and 0.86 (0.1) vol%, the Cp Alf values were 122 (35) and 181 (58) ng/ml, and the Bispectral Index values were 51 (9) and 52 (4) before surgery and during surgery, respectively. The mean (SD) absolute deviations of mean arterial blood pressure were 7.6 (2.6) and 10.0 (4.2) mmHg (P = 0.262), and the median performance error, median absolute performance error, and wobble were 4.2 (6.2) and 8.8 (9.4)% (P = 0.002), 7.9 (3.8) and 11.8 (6.3)% (P = 0.129), and 14.5 (8.4) and 5.7 (1.2)% (P = 0.002) before surgery and during surgery, respectively. A post hoc simulation showed that the Cp Alfref decreased the predicted Cp Alf compared with mean arterial blood pressure alone.
CONCLUSION: The authors' controller has a similar set-point precision as previous hypnotic controllers and provides adequate alfentanil dosing during surgery. It may help to standardize opioid dosing in research and may be a further step toward a multiple input-multiple output controller.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931977     DOI: 10.1097/00000542-200609000-00008

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

1.  Smart sensors for maintaining physiologic homeostasis.

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

2.  Impact of non invasive and beat-to-beat arterial pressure monitoring on intraoperative hemodynamic management.

Authors:  Guo Chen; Elena Chung; Lingzhong Meng; Brenton Alexander; Trung Vu; Joseph Rinehart; Maxime Cannesson
Journal:  J Clin Monit Comput       Date:  2012-03-01       Impact factor: 2.502

3.  IMPROVED TRANSFORMATION OF MORPHOMETRIC MEASUREMENTS FOR A PRIORI PARAMETER ESTIMATION IN A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF ETHANOL.

Authors:  Martin H Plawecki; Ray Decarlo; Vijay A Ramchandani; Sean O'Connor
Journal:  Biomed Signal Process Control       Date:  2007-04       Impact factor: 3.880

4.  Robotic anesthesia - a vision for the future of anesthesia.

Authors:  Thomas M Hemmerling; Riccardo Taddei; Mohamad Wehbe; Joshua Morse; Shantale Cyr; Cedrick Zaouter
Journal:  Transl Med UniSa       Date:  2011-10-17

5.  Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients.

Authors:  Pieter J Colin; Stijn Jonckheere; Michel M R F Struys
Journal:  Clin Pharmacokinet       Date:  2018-11       Impact factor: 6.447

6.  Development of an automated closed-loop β-blocker delivery system to stably reduce myocardial oxygen consumption without inducing circulatory collapse in a canine heart failure model: a proof of concept study.

Authors:  Takuya Nishikawa; Kazunori Uemura; Yohsuke Hayama; Toru Kawada; Keita Saku; Masaru Sugimachi
Journal:  J Clin Monit Comput       Date:  2021-05-10       Impact factor: 1.977

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.